Pharmagen Cash from 2010 to 2024
| PHRX Stock | USD 0.0001 0.00 0.00% |
Cash | First Reported 2010-12-31 | Previous Quarter 259.9 K | Current Value 163.4 K | Quarterly Volatility 80.1 K |
Check Pharmagen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmagen's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 6.3 M, as well as many indicators such as Price To Sales Ratio of 0.25, Dividend Yield of 0.0 or Days Sales Outstanding of 22.3 K. Pharmagen financial statements analysis is a perfect complement when working with Pharmagen Valuation or Volatility modules.
Pharmagen | Cash |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pharmagen Stock Analysis
When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.